CFO

TransCode Therapeutics Reports 2023 Results; Provides Business Update

Retrieved on: 
Wednesday, April 3, 2024
Research, Transcoding, Brain, Survival, CFO, TTX, Patient, Operating cost, RNA, Sale, CMC, Cancer, OTS, IND, AACR, Glioblastoma, Pancreatic cancer, Therapy, Genomics, CRISPR, Breast cancer, Melanoma, Debiopharm, FDA, Liver, IRB, Pharmaceutical industry

BOSTON, April 03, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today reported financial results for 2023 and recent business progress.

Key Points: 
  • BOSTON, April 03, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today reported financial results for 2023 and recent business progress.
  • “We believe 2023 was extremely productive and pivotal for TransCode.
  • The year was highlighted by preliminary clinical results from our Phase 0 clinical trial with radiolabeled TTX-MC138,” said Tom Fitzgerald, interim CEO and CFO of TransCode.
  • We also continued to achieve other important milestones, with the ultimate objective of fulfilling the promise of RNA therapeutics for oncology applications.

BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia

Retrieved on: 
Wednesday, April 3, 2024
Depression, Neurology, Schizophrenia, Patent, CFO, Opioid use disorder, OTCQB

The USPTO has issued U.S. Patent No.

Key Points: 
  • The USPTO has issued U.S. Patent No.
  • 11,793,801 entitled, “Treatment of Pain and Neurological Conditions”.
  • The patent is directed towards the use of a compound and composition and/or dosage form for treating pain, depression, and schizophrenia.
  • Lourdes Felix, CEO, CFO, and Director of BioCorRx Inc., and President, and Chairman of BioCorRx Pharmaceuticals Inc., commented, “The patented invention may offer a novel approach to reducing the severity of withdrawal symptoms for opioid use disorder compared to current standards of care."

TC Energy appoints Sean O’Donnell as Executive Vice-President and Chief Financial Officer

Retrieved on: 
Wednesday, April 3, 2024
Catholic higher education, J. P. Morgan, CFO, TRP, University, Catholic University of America, Utility, TC Energy, Senior, MBA, Quantum, News, Pleasure, Capital market, TSX, Investment, Plan, Partner, Power, Donald Duck filmography, Corporation, Management

The appointment of Mr. O’Donnell follows Mr. Hunter’s decision to leave the Company to pursue another opportunity in the energy sector.

Key Points: 
  • The appointment of Mr. O’Donnell follows Mr. Hunter’s decision to leave the Company to pursue another opportunity in the energy sector.
  • “Throughout his over 26 years with the Company, Joel has been a valued member of the TC Energy team, and a distinguished contributor to our success.
  • We wish Joel all the best in his next opportunity,” said François Poirier, President and Chief Executive Officer.
  • He also served as the Chief Financial Officer of Quantum’s first US independent power company and of the firm’s LNG export facility in Mexico.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against The Chemours Company (CC)

Retrieved on: 
Wednesday, April 3, 2024
Ethics, CC, CFO, GPM, Defendant, News, Controller, Suite, Court

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • ]”
    On this news, Chemours’ stock price fell $9.05, or 31.5%, to close at $19.67 on February 29, 2024, thereby injuring investors further.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palo Alto Networks, Snowflake, Chemours, and Evolv and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, April 3, 2024
Transport, Form 10-K, P.C, Audit committee, Palo Alto Networks, Risk, PANW, Air conditioning, Electronics, Snowflake Inc., Annual report, Ethics, Federation, Defendant, News, Controller, Refrigeration, IPO, Senior, SNOW, Adjustment, Growth, CFO, Weapon, School, Complaint, Plastic, Cryptocurrency

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • On this news, the price of Palo Alto Networks, Inc. common stock declined by $104.12 per share, or approximately 28%, on February 21, 2024.
  • which lowered credit consumption.”  On this news, the price of Snowflake Class A common stock fell nearly 28% over several trading sessions, damaging investors.
  • For more information on the Evolv class action go to: https://bespc.com/cases/EVLV

Sow Good Appoints Brendon Fischer as Interim Chief Financial Officer

Retrieved on: 
Tuesday, April 2, 2024
Dallas–Fort Worth metroplex, Moses Austin, CFO, Business, Business administration, Knowledge, Research, University, Food, CFA, McCombs School of Business, Sow, OTCQB

IRVING, Texas, April 02, 2024 (GLOBE NEWSWIRE) -- Sow Good Inc. (OTCQB: SOWG) ("Sow Good" or “the Company”), a trailblazer in the freeze dried candy and treat industry, announced today that Brendon Fischer has been appointed as the Company’s interim chief financial officer (CFO), following the resignation of the Company’s former CFO, Keith Terreri.

Key Points: 
  • IRVING, Texas, April 02, 2024 (GLOBE NEWSWIRE) -- Sow Good Inc. (OTCQB: SOWG) ("Sow Good" or “the Company”), a trailblazer in the freeze dried candy and treat industry, announced today that Brendon Fischer has been appointed as the Company’s interim chief financial officer (CFO), following the resignation of the Company’s former CFO, Keith Terreri.
  • Fischer first joined the Sow Good team in June 2023, bringing over 20 years of leadership experience in financial analysis, shareholder communications, and regulatory compliance with public and private companies.
  • Before joining Sow Good, Fischer served as the chief investment officer, managing director, and chief compliance officer of Fischer Capital Management, an investment advisory firm he founded in 2018.
  • We would like to thank Keith for his time at Sow Good and wish him all the best in his future endeavors.”

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME)

Retrieved on: 
Tuesday, April 2, 2024
Interim management, Senior, Interim, SVP, Zymeworks, News, CFO, Private investigator

NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME ).

Key Points: 
  • NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME ).
  • The investigation concerns whether Zymeworks and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On April 1, 2024, Zymeworks disclosed that it had removed Christopher Astle from the positions of Senior Vice President and Chief Financial Officer, effective immediately.
  • Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.

Independent Bank Corporation Announces Date for Its First Quarter 2024 Earnings Release

Retrieved on: 
Tuesday, April 2, 2024
Internet, Access code, Independent Bank (Michigan), CFO, Cryptocurrency

GRAND RAPIDS, Mich., April 02, 2024 (GLOBE NEWSWIRE) -- Independent Bank Corporation (NASDAQ: IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that it expects to issue its 2024 first quarter results on Thursday, April 25, 2024, at approximately 8:00 am ET.

Key Points: 
  • GRAND RAPIDS, Mich., April 02, 2024 (GLOBE NEWSWIRE) -- Independent Bank Corporation (NASDAQ: IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that it expects to issue its 2024 first quarter results on Thursday, April 25, 2024, at approximately 8:00 am ET.
  • The release will be available on the Internet at IndependentBank.com within the “News” section of the “Investor Relations” area of the Company’s website.
  • Also the conference call will be accessible through an audio webcast with user-controlled slides via the following event site/URL: https://events.q4inc.com/attendee/312593309 .
  • The replay will be available through May 3, 2024.

Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue

Retrieved on: 
Tuesday, April 2, 2024
MRD, Adaptation, Interim, Genetics, Investment, ADPT, CFO, Management

Management will provide further details on the process and outcome of the strategic review during the conference call this afternoon.

Key Points: 
  • Management will provide further details on the process and outcome of the strategic review during the conference call this afternoon.
  • Total revenue of approximately $41 to $43 million for the first quarter of 2024, an increase of approximately 12% compared to the first quarter of 2023.
  • MRD revenue of approximately $31 to $32 million for the first quarter of 2024, an increase of approximately 47% compared to the first quarter of 2023.
  • Adaptive Biotechnologies announced that Tycho Peterson, chief financial officer (CFO), will be departing the company to pursue another opportunity.

Avid Appoints Wellford Dillard as Chief Executive Officer

Retrieved on: 
Tuesday, April 2, 2024
Organization, Software as a service, Sport, Media, CFO, Avid Technology, Omnichannel, Social media, News, STG, Life, Music, Management

BURLINGTON, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Avid ®, a leading technology provider that powers the Media & Entertainment industry, today announced that it has appointed Wellford Dillard as the organization’s next Chief Executive Officer (CEO).

Key Points: 
  • BURLINGTON, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Avid ®, a leading technology provider that powers the Media & Entertainment industry, today announced that it has appointed Wellford Dillard as the organization’s next Chief Executive Officer (CEO).
  • Wellford joins Avid after serving as the CEO of Marigold, a leading provider of omni-channel marketing SaaS solutions, used by businesses to manage and deepen customer engagement.
  • “We are thrilled to appoint Wellford as the new CEO of Avid,” said William Chisholm, Managing Partner, and Patrick Fouhy, Principal, of STG.
  • Avid, the Avid logo, is a registered trademark of Avid Technology, Inc., or its subsidiaries in the United States and/or other countries.